BGM Group Ltd. SEC filings BGM
BGM Group Ltd. has 154 filings in SEC EDGAR's recent list, going back to Jun 17, 2019. Its latest annual report, Form 20-F, was filed on Jul 21, 2026 for the period ended Sep 30, 2025. The most recent current report (Form 6-K) was filed on Sep 24, 2026. The company's fiscal year ends on September 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| 3 | Initial insider ownership | May 14, 2026 | Mar 31, 2026 |
| 3 | Initial insider ownership | May 14, 2026 | Mar 31, 2026 |
| 3 | Initial insider ownership | May 14, 2026 | Mar 31, 2026 |
| 3 | Initial insider ownership | May 14, 2026 | Apr 28, 2026 |
| 3 | Initial insider ownership | Apr 13, 2026 | Apr 13, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 28, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 28, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | May 27, 2025 | — |
| SCHEDULE 13D | Ownership over 5% (active) | May 27, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 6, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 6, 2025 | — |
| SCHEDULE 13D | Ownership over 5% (active) | Jan 6, 2025 | — |
| SC 13D | Ownership over 5% (active) | Dec 3, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | Nov 29, 2024 | — |
| SC 13D | Ownership over 5% (active) | Oct 16, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 10, 2021 | — |
| SC 13G | Ownership over 5% (passive) | Feb 10, 2021 | — |
| SC 13G | Ownership over 5% (passive) | Feb 10, 2021 | — |
Showing 18 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BGM (Nasdaq)
- Fiscal year ends
- September 30
- Incorporated in
- Cayman Islands
- Headquarters
- Chengdu
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1779578
- Former names
- Qilian International Holding Group (until Oct 22, 2024); Qilian International Holding Group Ltd (until Oct 16, 2024)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.